in3

in3

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Douglas Connect (2 days ago)
Profit from the extended deadline (May 31) for early-bird rates for the #eChemInfo Training and Innovation Course i… https://t.co/DrnKO5j0O4
Douglas Connect (4 days ago)
RT @madAniceP: Continuation of #workshop to resolve your problems in #drugdesign. Excited to be a part of this event and looking forward to…
Douglas Connect (2 weeks ago)
OpenTox Asia 2018 begins next week! Join us in Tokyo to discuss systems toxicology and how we form a foundation for… https://t.co/i5beiwDCJE
Douglas Connect (3 weeks ago)
https://t.co/XlgYyhQD70
Douglas Connect (4 weeks ago)
@CRACK_IT Douglas Connect's latest App pulls 3Rs (Replacement, Reduction and Refinement of animal testing) knowledg… https://t.co/CoDH16tC5d

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com